⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Heraeus Holding GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Heraeus Holding GmbH
↗Hanau, Germany
Heraeus is a leading global, family-owned technology group headquartered in Hanau, Germany. The company operates as a diversified conglomerate with a focus on precious metals, medical technology, semiconductors, electronics, and industrial applications. It leverages deep materials science expertise to provide high-tech solutions across the entire value chain, from material development to recycling.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Revenue:€28.2B (2024)
Founded:1851
Ownership:private
Status:operating
FUNDING
Total Raised:$454M
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO/Supplier)
Modalities:Small molecule, Platinum-based HPAPIs
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Heraeus Electronics, Heraeus Precious Metals, Heraeus Medevio, Heraeus Covantics
Key Partnerships:Evonik (HPAPI services), BASF (Precious metal recycling joint venture)
COMPETITION
Position:Leader
Competitors:Umicore, Johnson Matthey, Thermo Fisher Scientific, Siemens
LEADERSHIP
Key Executives:
Marcus Hannakam - Executive Vice President, Pharmaceutical Ingredients
LINKS
Website:heraeus.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Heraeus Holding GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.